Macular atrophy development in neovascular age-related macular degeneration during first year of treatment: Incidence and risk factors. [electronic resource]
Producer: 20210604Description: 521-528 p. digitalISSN:- 1724-6016
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- therapeutic use
- Atrophy -- diagnostic imaging
- Choroidal Neovascularization -- drug therapy
- Female
- Fluorescein Angiography
- Humans
- Incidence
- Intravitreal Injections
- Macula Lutea -- diagnostic imaging
- Male
- Multimodal Imaging
- Prospective Studies
- Ranibizumab -- therapeutic use
- Receptors, Vascular Endothelial Growth Factor -- therapeutic use
- Recombinant Fusion Proteins -- therapeutic use
- Retrospective Studies
- Risk Factors
- Tomography, Optical Coherence -- methods
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Wet Macular Degeneration -- drug therapy
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.